We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rising Trend for Surgical Treatment of Chronic Constipation

By HospiMedica International staff writers
Posted on 21 Sep 2014
A new study reveals that colectomy rates for chronic constipation are increasing exponentially and causing considerable morbidity with little evidence for long-term benefit. More...


Researchers at the University of Pittsburgh Medical Center (UPMC; PA, USA) conducted a study to examine changing patterns in the use of colectomy for constipation and the rate of perioperative complications. To do so, they examined the US Nationwide Inpatient Sample for 1998 to 2011, as well as other sources, identifying 2,220 women and 157 men (aged 25–64 years) who underwent the procedure. Nearly 90% of the procedures were elective, and most were performed in large, urban teaching hospitals.

The analysis confirmed colectomy for constipation has increased dramatically in the United States since 1998, rising from 104 in 1998 to 311 in 2011, representing a 200% increase, and accounting for at least 2% of the annual colectomies performed. Most of the patients had a low perioperative risk, as defined by young age and limited co-morbidities, but clinical depression was present in 14.8% and psychotic diseases in 5.8% of the patients. Approximately 40% of the patients went on to develop a perioperative complication, with urinary and pulmonary problems accounting for about 50% of these events.

The study also revealed that 72.4% of the patients experienced at least one a readmission event within first 30 days. The data also demonstrated that neither the number of emergency room (ER) visits nor that of hospitalizations changed for these patients after surgery, with events dominated by gastrointestinal complaints, suggesting that the apparent risk of surgery was not offset by improved long-term outcomes. The study was presented at Digestive Disease Week (DDW), held during May 2014 in Chicago (IL, USA).

“While surgery was mostly performed in the young, perioperative complications were common. As a functional disorder, constipation may have a significant impact on quality of life, but it does not come with truly relevant morbidity or mortality,” said study presenter and coauthor Anwar Dudekula, MD. “Thus, the risks of more aggressive interventions need to be weighed against this generally benign prognosis.”

Surgical treatment of chronic functional constipation should be considered only in the most severe cases of slow-colonic-transit constipation, and for those patients who do not respond to aggressive medical therapy.

Related Links:

University of Pittsburgh Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.